Provence Technologies acquires Synprosis

The acquisition strengthens Provence Technologies’ expertise in its core business of therapeutic chemistry

Provence Technologies Group, a specialist fine chemistry research group, today announces its acquisition of Synprosis, a company specialized in the chemical synthesis of peptides and proteins for therapeutic use.

PDF - 108.8 kb